While weight loss trends aren't new to the American cultural experience, glucagon-like peptide-1 receptor agonists (colloquially referred to as GLP-1 medications), are the center of the national ...
Have Americans reached a tipping point when it comes to tipping? A new consumer survey from Popmenu, a technology company that services the restaurant industry, suggests as much. The key data point: ...
America’s obesity rate is on the decline, a new Gallup poll published Tuesday shows, falling nearly three percent as the use of popular GLP-1-class diabetes and weight loss drugs has surged. There are ...
The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey by the Gallup National Health and Well-Being Index.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results